Press releases

  • Monday, 23 February 2015

    Ferring Pharmaceuticals acquires novel drug delivery technology from CTCBIO Inc.

    Read press release
  • Friday, 20 February 2015

    Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy

    Read press release
  • Wednesday, 18 February 2015

    Ferring Pharmaceuticals acquires two phase III ready orthobiologic product candidates from BioSET

    Read press release
  • Tuesday, 27 January 2015

    Ferring Pharmaceuticals moves to strengthen growth with appointment of Chief Medical and Chief Scientific officers

    Read press release
Archive:

Helen Gallagher

Senior Director
Corporate Communications
Tel: +41 58 301 00 51

Patrick Gorman

Associate Director
Corporate Communications
Tel: +41 58 301 00 53

Corporate Communications

Ferring International Center S.A.
Ch. de la Vergognausaz 50
CH-1162 Saint-Prex
Switzerland
Tel: +41 58 301 00 00
Fax: +41 58 301 00 10
email

Headquarters

Ferring International Center S.A.
Ch. de la Vergognausaz 50
1162 Saint-Prex
Switzerland

Tel:  +41 58 301 00 00
Fax: +41 58 301 00 10

Contact

GLOBAL LOCATOR